Skip to main content
PMC home page
Environmental Health Perspectives logoLink to Environmental Health Perspectives
. 1990 Jul;87:43–49. doi: 10.1289/ehp.908743

Statistical problems in epidemiologic studies of the natural history of disease.

R Brookmeyer 1
PMCID: PMC1567819  PMID: 2269238

Abstract

The development of effective disease prevention and treatment programs depends on an understanding of the natural history of disease. A conceptual framework is presented for disease natural history and consists of an asymptomatic period of disease followed by a period of symptomatic disease. The focus is on epidemiologic studies for identifying risk factors of the onset of asymptomatic disease, for identifying cofactors of progression to symptomatic disease, and for estimating the duration of the asymptomatic period. The strengths and limitations of various epidemiologic study designs and sources of epidemiologic data are considered for characterizing disease natural history. Issues in the interpretation and analysis of natural history parameters of disease estimated from cross-sectional, prevalent cohort, cohort, and matched case-control studies are considered. The issues and analytic methods are illustrated with studies of the acquired immunodeficiency syndrome (AIDS) and cervical cancer. Based on these analytic methods, an estimate of the incubation period distribution of AIDS is given.

Full text

PDF
47

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Brookmeyer R., Day N. E., Moss S. Case-control studies for estimation of the natural history of preclinical disease from screening data. Stat Med. 1986 Mar-Apr;5(2):127–138. doi: 10.1002/sim.4780050204. [DOI] [PubMed] [Google Scholar]
  2. Brookmeyer R., Day N. E. Two-stage models for the analysis of cancer screening data. Biometrics. 1987 Sep;43(3):657–669. [PubMed] [Google Scholar]
  3. Brookmeyer R., Gail M. H. Biases in prevalent cohorts. Biometrics. 1987 Dec;43(4):739–749. [PubMed] [Google Scholar]
  4. Brookmeyer R., Gail M. H. Minimum size of the acquired immunodeficiency syndrome (AIDS) epidemic in the United States. Lancet. 1986 Dec 6;2(8519):1320–1322. doi: 10.1016/s0140-6736(86)91444-3. [DOI] [PubMed] [Google Scholar]
  5. Brookmeyer R., Goedert J. J. Censoring in an epidemic with an application to hemophilia-associated AIDS. Biometrics. 1989 Mar;45(1):325–335. [PubMed] [Google Scholar]
  6. Campion M. J., McCance D. J., Cuzick J., Singer A. Progressive potential of mild cervical atypia: prospective cytological, colposcopic, and virological study. Lancet. 1986 Aug 2;2(8501):237–240. doi: 10.1016/s0140-6736(86)92067-2. [DOI] [PubMed] [Google Scholar]
  7. Day N. E., Walter S. D. Simplified models of screening for chronic disease: estimation procedures from mass screening programmes. Biometrics. 1984 Mar;40(1):1–14. [PubMed] [Google Scholar]
  8. Eyster M. E., Gail M. H., Ballard J. O., Al-Mondhiry H., Goedert J. J. Natural history of human immunodeficiency virus infections in hemophiliacs: effects of T-cell subsets, platelet counts, and age. Ann Intern Med. 1987 Jul;107(1):1–6. doi: 10.7326/0003-4819-107-1-1. [DOI] [PubMed] [Google Scholar]
  9. Gail M. H., Brookmeyer R. Methods for projecting course of acquired immunodeficiency syndrome epidemic. J Natl Cancer Inst. 1988 Aug 17;80(12):900–911. doi: 10.1093/jnci/80.12.900. [DOI] [PubMed] [Google Scholar]
  10. Gallo R. C., Salahuddin S. Z., Popovic M., Shearer G. M., Kaplan M., Haynes B. F., Palker T. J., Redfield R., Oleske J., Safai B. Frequent detection and isolation of cytopathic retroviruses (HTLV-III) from patients with AIDS and at risk for AIDS. Science. 1984 May 4;224(4648):500–503. doi: 10.1126/science.6200936. [DOI] [PubMed] [Google Scholar]
  11. Kurman R. J., Schiffman M. H., Lancaster W. D., Reid R., Jenson A. B., Temple G. F., Lorincz A. T. Analysis of individual human papillomavirus types in cervical neoplasia: a possible role for type 18 in rapid progression. Am J Obstet Gynecol. 1988 Aug;159(2):293–296. doi: 10.1016/s0002-9378(88)80070-x. [DOI] [PubMed] [Google Scholar]
  12. Lorincz A. T., Temple G. F., Kurman R. J., Jenson A. B., Lancaster W. D. Oncogenic association of specific human papillomavirus types with cervical neoplasia. J Natl Cancer Inst. 1987 Oct;79(4):671–677. [PubMed] [Google Scholar]
  13. Walter S. D., Day N. E. Estimation of the duration of a pre-clinical disease state using screening data. Am J Epidemiol. 1983 Dec;118(6):865–886. doi: 10.1093/oxfordjournals.aje.a113705. [DOI] [PubMed] [Google Scholar]

Articles from Environmental Health Perspectives are provided here courtesy of National Institute of Environmental Health Sciences

RESOURCES